249 related articles for article (PubMed ID: 25403548)
1. Treatment of pemphigus vulgaris and pemphigus foliaceus: a systematic review and meta-analysis.
Atzmony L; Hodak E; Gdalevich M; Rosenbaum O; Mimouni D
Am J Clin Dermatol; 2014 Dec; 15(6):503-15. PubMed ID: 25403548
[TBL] [Abstract][Full Text] [Related]
2. Interventions for pemphigus vulgaris and pemphigus foliaceus.
Martin LK; Werth V; Villanueva E; Segall J; Murrell DF
Cochrane Database Syst Rev; 2009 Jan; (1):CD006263. PubMed ID: 19160272
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus.
Martin LK; Werth VP; Villaneuva EV; Murrell DF
J Am Acad Dermatol; 2011 May; 64(5):903-8. PubMed ID: 21353333
[TBL] [Abstract][Full Text] [Related]
4. The role of adjuvant therapy in pemphigus: A systematic review and meta-analysis.
Atzmony L; Hodak E; Leshem YA; Rosenbaum O; Gdalevich M; Anhalt GJ; Mimouni D
J Am Acad Dermatol; 2015 Aug; 73(2):264-71. PubMed ID: 26088689
[TBL] [Abstract][Full Text] [Related]
5. Pemphigus vulgaris: an evidence-based treatment update.
Zhao CY; Murrell DF
Drugs; 2015 Feb; 75(3):271-84. PubMed ID: 25655250
[TBL] [Abstract][Full Text] [Related]
6. [Pemphigus: a review].
Joly P; Sin C
Ann Dermatol Venereol; 2011 Mar; 138(3):182-200. PubMed ID: 21397148
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Doukaki S; Platamone A; Alaimo R; Bongiorno MR
J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
[TBL] [Abstract][Full Text] [Related]
9. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
[TBL] [Abstract][Full Text] [Related]
10. Network meta-analysis-based comparison of first-line steroid-sparing adjuvants in the treatment of pemphigus vulgaris and pemphigus foliaceus.
Lee MS; Yeh YC; Tu YK; Chan TC
J Am Acad Dermatol; 2021 Jul; 85(1):176-186. PubMed ID: 32798583
[TBL] [Abstract][Full Text] [Related]
11. Enteric-coated mycophenolate sodium as a steroid-sparing agent in pemphigus treatment: a retrospective study.
De Simone C; Caldarola G; Perino F; Venier A; Guerriero G
Dermatol Ther; 2012; 25(2):219-22. PubMed ID: 22741942
[TBL] [Abstract][Full Text] [Related]
12. Feline pemphigus foliaceus in non-specialist veterinary practice: a retrospective analysis.
Coyner K; Tater K; Rishniw M
J Small Anim Pract; 2018 Sep; 59(9):553-559. PubMed ID: 29961990
[TBL] [Abstract][Full Text] [Related]
13. Pemphigus vulgaris treated with adalimumab: case study.
Vojáčková N; Fialová J; Vaňousová D; Hercogová J
Dermatol Ther; 2012; 25(1):95-7. PubMed ID: 22591504
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial.
van Beek N; Eming R; Reuss A; Zillikens D; Sárdy M; Günther C; Kiritsi D; Benoit S; Beissert S; Gläser R; Gollnick H; Horváth ON; Pfeiffer C; Röcken M; Schauer F; Schreml S; Steinbrink K; Zink A; Schade-Brittinger C; Hertl M; Schmidt E
Br J Dermatol; 2024 Apr; 190(5):657-667. PubMed ID: 38133541
[TBL] [Abstract][Full Text] [Related]
15. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based treatments in pemphigus vulgaris and pemphigus foliaceus.
Frew JW; Martin LK; Murrell DF
Dermatol Clin; 2011 Oct; 29(4):599-606. PubMed ID: 21925004
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial.
Dastgheib L; Sadati MS; Baghernejhad M
J Dermatolog Treat; 2015 Feb; 26(1):90-3. PubMed ID: 24552352
[TBL] [Abstract][Full Text] [Related]
18. Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent.
Katz KH; Marks JG; Helm KF
J Am Acad Dermatol; 2000 Mar; 42(3):514-5. PubMed ID: 10688729
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil.
Mimouni D; Anhalt GJ; Cummins DL; Kouba DJ; Thorne JE; Nousari HC
Arch Dermatol; 2003 Jun; 139(6):739-42. PubMed ID: 12810504
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M
J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
